Identification of novel biomarkers for early diagnosis of malignant melanoma by untargeted LC-HRMS-based metabolomics: a pilot study.
Jesús Peña-MartínMaría Belén García-OrtegaJosé Luis Palacios-FerrerCaridad DíazMaría Ángel GarcíaHouria BoulaizJavier ValdiviaJosé Miguel JuradoFrancisco M Almazan-FernandezSalvador Arias SantiagoFrancisca VicenteCoral Del ValJosé Pérez Del PalacioJuan Antonio Marchal CorralesPublished in: The British journal of dermatology (2024)
These results demonstrate that metabolomics using LC-HRMS is a powerful tool to identify and quantify metabolites in body fluids that could serve as potential early diagnostic markers for MM.